MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Wiltshire Capital
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital - In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007
The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital

 

NewswireToday - /newswire/ - Nishi-Shinjuku, Tokyo, Japan, 2011/05/04 - In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The biotechnology market is an ever-expanding, demanding, and lucrative market. Areas of the biotechnology market include; agriculture GMO, antibody technologies, antisense technology, biomaterials, biopharmaceuticals, drug discovery, emerging technology, environmental/industrial biotechnology, enzymes, gene therapy, general biotechnology, genetic engineering, genomics, informatics, instrumentation and equipment, molecular biology, pharmaceuticals, proteomics, regulation and bioethics, research and development, tissue engineering and wound care.

In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007. In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.

Malaysia has emerged as a major investment destination for biotech companies. The Malaysian biotech market posted high growth last year and is expected to do the same in next few years. Rich biodiversity, availability of low cost human resources and strong government efforts are some of the reasons that have boosted growth in the market. The biotech market in Malaysia is expected to grow around 21% during 2010-2012.

Wiltshire Capital (witshirecapital.com) has studied the Malaysian biotech market by breaking it into three segments – healthcare biotech, agriculture biotech and industrial biotech. Each of these segments has been extensively covered, giving in-depth analysis of the current and future market trends along with valuable data of past trends. The report also provides a complete overview of regulatory environment for the biotech market.

Wiltshire Capital’s report has found that increasing prevalence of diseases and rising exports of drugs from Malaysia are driving growth in the healthcare biotechnology market. This segment holds the highest potential for growth and will post the fastest growth rate among all the three segments.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Wiltshire Capital

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The Biotechnology Market to Reach $275M by 2012 Finds Wiltshire Capital

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Kaito Hiroshi - WiltshireCapital.com 
+81 345-790199 pr[.]wiltshirecapital.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Wiltshire Capital securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Wiltshire Capital / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)